Price Target Basis: 30x FY28E EPS of ₹80, discounted for regulatory and competitive risk
We value BSE on ~30x our FY28E EPS of ₹80 — a sharp de-rating from the current 48x trailing / ~41x forward multiple — reflecting (1) the cyclical, regulatory-exposed nature of the ~74% of revenue from derivatives transaction charges, (2) the structural primacy of NSE in Indian derivatives, and (3) the law of large numbers as 60%+ revenue growth collides with a ₹5,800 Cr TTM revenue base and flattening sequential prints (Q1FY27 revenue was flat QoQ at ₹1,566 Cr). Our PT implies ~10.5x our FY28E book value of ~₹230 — still a premium to global exchange peers (CME ~4x, ICE ~6x, Deutsche Börse ~4x book) — and we see asymmetric risk to consensus, which remains anchored to a growth story whose easy decade of share gains is behind it.
| Scenario | FY28E EPS | Multiple | Price | Implied return | Key assumption |
|---|
| Bear | ₹70 | 22x | ₹1,540 | −54% | Further SEBI tightening; expiry-day turf war; volumes mean-revert |
| Base | ₹80 | 30x | ₹2,400 | −28% | Growth decelerates to low-teens; multiple normalizes |
| Bull | ₹92 | 45x | ₹4,140 | +24% | Volume momentum persists; NSE response limited |
Risk-reward is unattractive: ~−54% / −28% / +24% across bear/base/bull, skewed to the downside given that the bull case requires the status quo of peak regulatory forbearance and peak retail derivatives speculation to persist.
Five reasons we are UNDERWEIGHT
- Valuation prices in perfection at the peak of a volume cycle (high conviction). At ₹3,328, BSE trades at 47.9x trailing earnings, ~40.8x forward, ~17x consolidated book, ~23x sales and ~29x EV/EBITDA — for a business whose dominant revenue line (transaction charges: ₹3,795 Cr in FY26 = 74% of revenue) is a function of daily options turnover, not a contractual annuity. The FY22–FY26 earnings CAGR of ~77% is being capitalized as if durable; we believe it was a one-time re-rating of share gains, retail speculation and near-zero incremental cost. The stock is a 2,000%+ five-year tenbagger — expectations are embedded.
- Regulatory dependency is existential, not peripheral (high conviction). BSE's earnings are a levered call option on SEBI's tolerance of retail index-options speculation. The December-24 quarter already showed what tightening does: revenue fell QoQ and operating margin collapsed from 56% to 31% in a single print.
- Deceleration is arriving on schedule. Q1FY27 revenue was flat QoQ at ₹1,566 Cr despite the June expiry advantage; street FY27 models still embed high-teens-plus growth.
- Margin normalization. 78% TTM operating margins invite competition, regulation and cost reinvestment; we model margins fading to the mid-60s as expiry-day economics get competed and regulated down.
- NSE primacy and the law of large numbers. NSE's response capacity — product depth, liquidity network effects — caps BSE's take-rate runway precisely when its revenue base has become large.
Quarterly trajectory (₹ Cr, consolidated)
| Quarter | Revenue | Op. profit | OPM |
|---|
| Jun-24 | 602 | 282 | 47% |
| Sep-24 | 813 | 456 | 56% |
| Dec-24 (SEBI F&O curbs) | 768 | 236 | 31% |
| Mar-25 | 847 | 484 | 57% |
| Jun-25 | 958 | 625 | 65% |
| Sep-25 | 1,068 | 680 | 64% |
| Dec-25 | 1,244 | 732 | 59% |
| Mar-26 | 1,564 | 1,041 | 67% |
| Jun-26 | 1,566 | 1,046 | 67% — flat QoQ |
Revenue mix (FY26)
| Segment | ₹ mn | % of revenue | Comment |
|---|
| Transaction charges | 37,950 | 74% | Options-flow driven; cyclical; regulatory-sensitive |
| Services to corporates (listings etc.) | 5,190 | 10% | IPO-cycle linked |
| Treasury / clearing-settlement income | 1,714 | 3% | Rate-linked |
| Other operating income | 3,485 | 7% | Data / connectivity / vending |
| Investment income on own corpus | — | ~6% | On ₹55 bn+ net cash |
Catalysts
Downside (toward our PT)
- Further SEBI derivative-tightening measures (expiry-day rationalization, margin hikes, new levies)
- QoQ revenue decline in FY27 prints confirming deceleration; margin normalization below ~60%
- NSE product/pricing retaliation compressing BSE's take rate
- Indian market drawdown / FII de-risking hitting retail derivatives participation
Upside (risks to our view)
- Volume momentum persists; BSE retains/extends its expiry-day advantage
- SEBI softens stance; retail F&O participation re-accelerates
- New revenue engines scale (India International Exchange flows, data services, clearing corp)
- Continued index-inclusion / passive flows into the stock itself
Company Description
BSE Ltd (Asia's oldest exchange, est. 1875; listed 2017) operates India's second-largest stock exchange, providing trading in equities, equity derivatives (Sensex/Sensex-50 complex), currencies, debt, and mutual-fund distribution (StAR MF). Revenue is dominated by derivatives transaction charges; the model is asset-light and debt-free, and carries among the highest operating margins (~78% TTM) in Indian financials.
Financial summary (₹ mn unless stated)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 | FY27E | FY28E |
|---|
| Operating income | 2,706 | 8,505 | 21,615 | 39,580 | 45,194 | ~44,000 | ~48,000 |
| Operating margin | 29.2% | 54.2% | 67.3% | 77.2% | 78.1% | ~66% | ~64% |
| Net income | 2,207 | 7,784 | 13,259 | 24,970 | 28,316 | ~31,000 | ~33,000 |
| EPS (₹, post-split) | 5.35 | 18.89 | 32.18 | 60.61 | 68.74 | ~75 | ~80 |
| ROE | 6.4% | 18.3% | 28.6% | 37.1% | ~42% | ~40% | ~35% |
| P/E (x, at ₹3,328) | 622x | 176x | 103x | 54.9x | 48.4x | 44.4x | 41.6x |
| Net cash (₹ mn) | 17,559 | 41,075 | 43,814 | 55,034 | 55,034 | — | — |
FY23–FY26 per S&P Global / StockAnalysis consolidated data; FY27E/28E are our illustrative estimates. Post 2:1 split; EPS restated. P/E on current price. Net income includes investment gains — the "clean" core P/E is higher.
Data sources: S&P Global via StockAnalysis.com, Screener.in, Economic Times, Business Today (as of 27 Aug 2026). This document is an AI-generated research note prepared for information and illustration only. It is not investment advice, not an offer to transact, and is not affiliated with or endorsed by any broker or bank. Figures are compiled from third-party public sources that may be delayed or revised. Equity investments carry risk of loss; consult a SEBI-registered investment adviser before acting.